UBS Group
BRSHW

UBS Group’s Bruush Oral Care Inc. Warrant BRSHW Stock Holding History

UBS Group’s Portfolio BRSHW Stock Details BRSHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-410
Closed -$49 – 9962
2023
Q1 		$49 Buy
+410
New +$45 ﹤0.01% 9343

Other funds holding BRSHW

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group's BRSHW Position: Q2 2023 in Review

UBS Group sold out of Bruush Oral Care Inc. Warrant (BRSHW) in Q2 2023, closing a stake of 410 shares — an estimated $49 sold.

UBS Group first reported a position in BRSHW in Q1 2023 and held it in 1 quarter. The position peaked at $49 in Q1 2023. 8 funds tracked by Wall St. Rank hold BRSHW as of Q2 2023.

  • UBS Group reported no remaining Bruush Oral Care Inc. Warrant position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 410 Bruush Oral Care Inc. Warrant shares in Q2 2023, an estimated $49.
  • UBS Group first reported a position in Bruush Oral Care Inc. Warrant in Q1 2023 and held it in 1 quarter.
  • UBS Group's Bruush Oral Care Inc. Warrant position peaked at $49 in Q1 2023.
  • 8 funds tracked by Wall St. Rank held Bruush Oral Care Inc. Warrant as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.